ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

NCI Role, Issues In Education Considered By DRCCA Board

August 21, 1981

Clinical Trials Approved By NCI Last Month Are Listed

January 25, 2002

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

March 4, 1983

Peters Leaves NCI For CF Foundation

February 3, 1978